Volume 16, Issue 3 (8-2024)                   IJDO 2024, 16(3): 144-148 | Back to browse issues page

XML Print


Diabetes Research Center, Sahid Sadoughi University of Medical Sciences,Yazd, Iran
Abstract:   (226 Views)
Objective: Type 2 Diabetes mellitus (T2DM) is the most prevent metabolic disease. Gender differences are important in the epidemiology, pathophysiology, and treatment of many diseases. The aim of this study is to investigate the gender effect on laboratory variables and complications in patients with T2DM.
Materials and Methods: In this descriptive cross-sectional study, patients with T2DM between 35 -65 years old who referred to Diabetes Research Center, Yazd, Iran during 2018-2019 were studied. Demographic features and clinical information of patients were extracted from patients' medical records. All information and variables were examined in two groups according to gender and the data were analyzed using SPSS 19.
Results: Totally, 1931 patients were enrolled in the study (988 females and 943 males). Most of the patients (68.6%) were treated with insulin. Body mass index was higher in women than in men. The variables of LDL (P= 0.029), triglyceride (P< 0.001) and retinopathy (P= 0.021), were significantly different between men and women.
Conclusion: The results of this study showed there are significant differences between male and female patients with T2DM in terms of lipid profiles and retinopathy.
 
Full-Text [PDF 439 kb]   (131 Downloads)    
Type of Study: Research | Subject: Special
Received: 2024/02/4 | Accepted: 2024/06/10 | Published: 2024/08/20

References
1. Entezari Z, Injinari N, Vakili M, Namiranian N. Identification of Factors Related to Sexual Dysfunction in Type 2 Diabetic Women. Iranian journal of diabetes and obesity. 2023; 15(2): 66-72. [DOI:10.18502/ijdo.v15i2.12963]
2. Mehrabbeik A, Azizi R, Rahmanian M, Namiranian N, Shukohifar M, Asi M. Design and Psychometrics of Diabetes Knowledge Questionnaire. Journal of Medical Education. 2022;21(1): e130597. [DOI:10.5812/jme-130597]
3. Hafez SM, Allam FA, Elbassuoni E. Sex differences impact the pancreatic response to chronic immobilization stress in rats. Cell Stress and Chaperones. 2021;26(1):199-215. [DOI:10.1007/s12192-020-01169-y]
4. Rosen ED, Kaestner KH, Natarajan R, Patti ME, Sallari R, Sander M, et al. Epigenetics and epigenomics: implications for diabetes and obesity. Diabetes. 2018;67(10):1923-31. [DOI:10.2337/db18-0537]
5. Ciarambino T, Crispino P, Leto G, Mastrolorenzo E, Para O, Giordano M. Influence of gender in diabetes mellitus and its complication. International journal of molecular sciences. 2022;23(16):8850. [DOI:10.3390/ijms23168850]
6. Kautzky-Willer A, Harreiter J. Sex and gender differences in therapy of type 2 diabetes. Diabetes Research and Clinical Practice. 2017;131:230-41. [DOI:10.1016/j.diabres.2017.07.012]
7. Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities. Circulation. 2019;139(24):2742-53. [DOI:10.1161/CIRCULATIONAHA.118.039100]
8. Hendriks SH, Blanker MH, Roelofsen Y, van Hateren KJ, Groenier KH, Bilo HJ, et al. Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52). BMC Health Services Research. 2018;18:1-9. [DOI:10.1186/s12913-018-3086-x]
9. Azimi-Nezhad M, Ghayour-Mobarhan MP, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore medical journal. 2008;49(7):571.
10. Shahwan MJ, Jairoun AA, Farajallah A, Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(4):2387-92. [DOI:10.1016/j.dsx.2019.06.009]
11. Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities. Circulation. 2019;139(24):2742-53. [DOI:10.1161/CIRCULATIONAHA.118.039100]
12. Peters SA, Woodward M. Sex differences in the burden and complications of diabetes. Current diabetes reports. 2018;18(6): 33. [DOI:10.1007/s11892-018-1005-5]
13. Holven KB, van Lennep JR. Sex differences in lipids: a life course approach. Atherosclerosis.2023;384:117270. [DOI:10.1016/j.atherosclerosis.2023.117270]
14. Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The importance of gender to understand sex differences in cardiovascular disease. Canadian Journal of Cardiology. 2021 ;37(5):699-710. [DOI:10.1016/j.cjca.2021.02.005]
15. Hussain A, Ali I, Kaleem WA, Yasmeen F. Correlation between body mass index and lipid profile in patients with type 2 diabetes attending a tertiary care hospital in Peshawar. Pakistan journal of medical sciences.2019;35(3):591-7. [DOI:10.12669/pjms.35.3.7]
16. Găman MA, Cozma MA, Dobrică EC, Bacalbașa N, Bratu OG, Diaconu CC. Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes. Metabolites. 2020;10(5):195. [DOI:10.3390/metabo10050195]
17. Angoulvant D, Ducluzeau PH, Renoult-Pierre P, Fauchier G, Herbert J, Semaan C, et al. Impact of gender on relative rates of cardiovascular events in patients with diabetes. Diabetes & metabolism. 2021;47(5):101226. [DOI:10.1016/j.diabet.2021.101226]
18. Cherchi S, Gigante A, Spanu MA, Contini P, Meloni G, Fois MA, et al. Sex-gender differences in diabetic retinopathy. Diabetology. 2020;1(1):1-10. [DOI:10.3390/diabetology1010001]
19. Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, Flaxman AD. Prevalence of diabetic retinopathy in the US in 2021. JAMA ophthalmology. 2023;141(8):747-54. [DOI:10.1001/jamaophthalmol.2023.2289]
20. Li M, Wang Y, Liu Z, Tang X, Mu P, Tan Y, et al. Females With Type 2 Diabetes Mellitus Are Prone to Diabetic Retinopathy: A Twelve‐Province Cross‐Sectional Study in China. Journal of diabetes research. 2020;2020(1):5814296. [DOI:10.1155/2020/5814296]
21. Hashemi H, Rezvan F, Pakzad R, Ansaripour A, Heydarian S, Yekta A, et al. Global and Regional Prevalence of Diabetic Retinopathy; A Comprehensive Systematic Review and Meta-analysis. Seminars in Ophthalmology. 2022;37(3):291-306. [DOI:10.1080/08820538.2021.1962920]
22. Sultan S, Fawwad A, Siyal NA, Butt A, Khokar AR, Basit A. Frequency and risk factors of diabetic retinopathy in patients with type 2 diabetes presenting at a tertiary care hospital. International Journal of Diabetes in Developing Countries. 2020;40:87-92. [DOI:10.1007/s13410-019-00756-9]
23. Giandalia A, Giuffrida AE, Gembillo G, Cucinotta D, Squadrito G, Santoro D, et al. Gender differences in diabetic kidney disease: focus on hormonal, genetic and clinical factors. International journal of molecular sciences. 2021;22(11):5808. [DOI:10.3390/ijms22115808]
24. Thomas B. The Global Burden of Diabetic Kidney Disease: Time Trends and Gender Gaps. Current Diabetes Reports. 2019;19(4):18. [DOI:10.1007/s11892-019-1133-6]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.